breaking news

Dr. Peter McCullough: Ivermectin Early Treatment & What To Do If Your Doctor Refuses

admin

“In high-risk people, typically seniors over 65, within the first few days, there is a 50% reduction off the bat with hospitalization. If you don’t get hospitalized, you’re not going to go on to die. And you know, that’s just what the monoclonal antibodies. And America saw Former President Trump received them. Governor Abbott, a vaccine breakthrough case, he received them recently podcaster Joe Rogan. Joe Rogan got them. Dan Ball had me on Real America, said what do you think about Joe Rogan? I said Joe Rogan got the treatment that I drew up for America. He got diagnosed properly, he got monoclonal antibodies, moved into ivermectin, corticosteroids, received the other drugs in sequence. And for Joe Rogan, a big guy, and the virus preys on big guys like that, you know, big men actually can get slaughtered by the virus. Joe Rogan took a two to four week illness and made it a three-day affair. That should be the standard for Americans, United States, anybody listening to this, let’s not have another senior citizen sit at home and be told there’s no treatment. Let’s get activated. Everybody needs to know where these monoclonal antibodies infusions are. Download the protocols that we’re going to go over. You can get them from the Truth or Health Foundation, American Frontline Doctors, the Association of American Physicians and Surgeons. These are the most widely used protocols in the United States, and call your doctor and say, Doctor, are you willing to treat me if I get COVID-19? I’m coming up with an action plan. If he says no, I don’t treat COVID, or there’s no treatment, say ask for a referral. If you can’t do it, find me a real Doctor who can.” – Dr. Peter McCullough

In, ,

8 thoughts on “Dr. Peter McCullough: Ivermectin Early Treatment & What To Do If Your Doctor Refuses”

  1. Why does Dr. Fauci, our CDC and FDA continue to lie to America and hide the data?
    It appears that they want to destroy America and the American people don’t even know this!!
    It seems like India and other countries of the world are winning the Covid fight and America is losing.

    Reply

  2. Dr. I do not want shot and I never plan to to get it. I take all natural products. I do have Afib and I take Dixogen for order by my doctor. I am a believer and watch Marcus and Joni on DayStar. I have seen you on there and others how they Ivermectin is good for prevention. I read stuff about it sounds like it bad side effects for some like with my heart situation. Besides there isn’t anywhere I can get it. I am 80 and in good shape .

    Reply

  3. I’m extremely pleased to discover this great site. I want to to thank you for ones time due to this fantastic read!!
    I definitely loved every bit of it and i also have you bookmarked to look at new stuff on your site.

    Reply

Leave a Reply

Your email address will not be published.

More Stories

SARS-CoV-2 Spike Proteins and Cell-Cell Communication Inhibits TFPI and Induces Thrombogenic Factos in Human Lung Microvascular Endothelial Cell and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenisis

In SARS-CoV-2-infected humans, disease progression is often associated with acute respiratory distress syndrome involving severe lung injury, coagulopathy, and thrombosis of the alveolar capillaries. The pathogenesis of these pulmonary complications in COVID-19 patients has not been elucidated. Autopsy study of these patients showed SARS-CoV-2 virions in pulmonary vessels and sequestrated leukocytes infiltrates associated with endotheliopathy and microvascular thrombosis. Since SARS-CoV-2 enters and infects target cells by binding its spike (S) protein to cellular angiotensin-converting enzyme 2 (ACE2), and there is evidence that vascular endothelial cells and neutrophils express ACE2, we investigated the effect of S-proteins and cell–cell communication on primary human lung microvascular endothelial cells (HLMEC) and neutrophils expression of thrombogenic factors and the potential mechanisms. Using S-proteins of two different SARS-CoV-2 variants (Wuhan and Delta), we demonstrate that exposure of HLMEC or neutrophils to S-proteins, co-culture of HLMEC exposed to S-proteins with non-exposed neutrophils, or co-culture of neutrophils exposed to S-proteins with non-exposed HLMEC induced transcriptional upregulation of tissue factor (TF), significantly increased the expression and secretion of factor (F)-V, thrombin, and fibrinogen and inhibited tissue factor pathway inhibitor (TFPI), the primary regulator of the extrinsic pathway of blood coagulation, in both cell types. Recombinant (r)TFPI and a thiol blocker (5,5′-dithio-bis-(2-nitrobenzoic acid)) prevented S-protein-induced expression and secretion of Factor-V, thrombin, and fibrinogen. Thrombomodulin blocked S-protein-induced expression and secretion of fibrinogen but had no effect on S-protein-induced expression of Factor-V or thrombin. These results suggests that following SARS-CoV-2 contact with the pulmonary endothelium or neutrophils and endothelial–neutrophil interactions, viral S-proteins induce coagulopathy via the TF pathway and mechanisms involving functional thiol groups. These findings suggest that using rTFPI and/or thiol-based drugs could be a viable therapeutic strategy against SARS-CoV-2-induced coagulopathy and thrombosis. View Full-Text

admin

Recent Post

Top Category

breaking news

Podcast

testimonials

Physicians Resources